TY

Tetsuya Yamagata

Chief Technology Officer, Senior VP

Modalis Therapeutics

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Modalis Therapeutics
Industry
research
Employees
24.0
Seniority
C suite

Technologies

Gmail Google Apps Google Analytics Apache WordPress.org Mobile Friendly Google Tag Manager Circle Remote

Keywords

biotechnology research crispr gene therapy genome editing crispr-gndm dna modification genetic engineering rna technology adeno associated virus grna dcas9 ex vivo studies in vivo studies biopharmaceuticals therapeutic development clinical trials genetic disorders biotechnology novel therapies precision medicine targeted gene therapies genomic innovations medical biotechnology cellular therapy molecular biology therapeutic pipelines regenerative medicine healthcare solutions translational medicine pharmaceutical research disease modification research & development genetic treatment therapy platforms collaborative initiatives scientific advancements clinical applications transformative medicine medical research health innovation genomic research cellular modification genome editing technologies research collaborations advancements in gene therapy sustainability in biotech ethical considerations in biotechnology stakeholder engagement therapeutic efficacy market potential investment opportunities health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans